Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
Cancer Immunology, Immunotherapy : CII|August 19, 2017
Novel prostate cancer immunotherapy with a DNA-encoded anti-prostate-specific membrane antigen monoclonal antibodyKar Muthumani, Liron Marnin, Sagar B Kudchodkar, et al.
Journal of Clinical Microbiology|August 29, 2020
SARS-CoV-2 Assays To Detect Functional Antibody Responses That Block ACE2 Recognition in Vaccinated Animals and Infected PatientsSusanne N Walker, Neethu Chokkalingam, Emma L Reuschel, et al.
The New England Journal of Medicine|September 15, 2021
Safety and Immunogenicity of an Anti-Zika Virus DNA VaccinePablo Tebas, Christine C Roberts, Kar Muthumani, et al.
JCI Insight|April 22, 2021
Intradermal delivery of a synthetic DNA vaccine protects macaques from Middle East respiratory syndrome coronavirusAmi Patel, Emma L Reuschel, Ziyang Xu, et al.
Nature Communications|February 12, 2025
DNA immunotherapy for recurrent respiratory papillomatosis (RRP): phase 1/2 study assessing efficacy, safety, and immunogenicity of INO-3107Matthew P Morrow, Elisabeth Gillespie, Albert Sylvester, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|January 29, 2026
A Phase Ib, Placebo-controlled Randomized Clinical Trial of the Ebolavirus DNA Vaccine Candidate INO-4201 Followed by Electroporation as Booster Vaccination in Healthy, rVSVΔG-ZEBOV-GP-primed Volunteers (Boost-EBOV)Angela Huttner, Marc-Antoine de La Vega, Cristina Boehm-Bosmani, et al.
Nature Communications|February 5, 2022
Induction of tier-2 neutralizing antibodies in mice with a DNA-encoded HIV envelope native like trimerZiyang Xu, Susanne Walker, Megan C Wise, et al.
Vaccine|April 16, 2022
Prime-boost vaccination regimens with INO-4800 and INO-4802 augment and broaden immune responses against SARS-CoV-2 in nonhuman primatesJewell N Walters, Blake Schouest, Ami Patel, et al.
Science Translational Medicine|August 21, 2015
A synthetic consensus anti-spike protein DNA vaccine induces protective immunity against Middle East respiratory syndrome coronavirus in nonhuman primatesKaruppiah Muthumani, Darryl Falzarano, Emma L Reuschel, et al.
Frontiers in Immunology|November 10, 2025
Safety, tolerability, and immunogenicity of INO-4500, a synthetic DNA-based vaccine against Lassa virus, in a phase 1b clinical trial in healthy Ghanaian adultsKwadwo Ansah Koram, Kathleen A Walker, Bonaventure Orizu, et al.
Pageof 3